Literature DB >> 12699324

Bioterrorism and critical care.

Manoj Karwa1, Patricia Bronzert, Vladimir Kvetan.   

Abstract

A bioterrorist attack of any kind has the potential to overwhelm a community and, indeed, in the case of smallpox, an entire nation. During such an attack the number of patients requiring hospitalization and specifically critical care is likely to be enormous. Intensivists will be at the forefront of this war and will play an important role in dealing with mass casualties in an attempt to heal the community. A high degree of suspicion and prompt recognition of an event will be required to contain it. Specific knowledge of the possible agents that can be used will be key in managing patients and in estimating the needs of a health care facility and community to deal with the future course of events. Intensivists play various roles aside from the delivery of critical care to the patient in the ICU. These roles include making triage decisions regarding the appropriate use of critical care beds (which automatically dictates how other non-ICU beds are used and managed) and serving as a team member of ethics committees (on such issues as dying, futility, and withdrawal of care). Indeed, intensivists are no strangers to disaster management and have served on the forefront of many. A biologic weapons attack, however, is likely to push this multidimensional nature of the intensivist to the maximum, because such an attack is likely to result in a more homogeneous critically ill population where the number of critical care staff and supplies to treat the victims may be limited. One hopes that such an event will not occur. Sadly, however the events of September 11, 2001, have only heightened the awareness of such a possibility.

Entities:  

Mesh:

Year:  2003        PMID: 12699324     DOI: 10.1016/s0749-0704(02)00053-2

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  10 in total

Review 1.  Respiratory medical societies and the threat of bioterrorism.

Authors:  T G O'Riordan; G C Smaldone
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

2.  Pandemic influenza: implications for preparation and delivery of critical care services.

Authors:  Mary-Elise Manuell; Mary Dawn T Co; Richard T Ellison
Journal:  J Intensive Care Med       Date:  2011-01-10       Impact factor: 3.510

3.  An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis.

Authors:  Jian Jiang; Carol E Parker; James R Fuller; Thomas H Kawula; Christoph H Borchers
Journal:  Anal Chim Acta       Date:  2007-10-23       Impact factor: 6.558

4.  The role of internists during epidemics, outbreaks, and bioterrorist attacks.

Authors:  Bruce Y Lee
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

Review 5.  Clinical review: SARS - lessons in disaster management.

Authors:  Laura Hawryluck; Stephen E Lapinsky; Thomas E Stewart
Journal:  Crit Care       Date:  2005-01-13       Impact factor: 9.097

Review 6.  Clinical review: Emergency department overcrowding and the potential impact on the critically ill.

Authors:  Robert M Cowan; Stephen Trzeciak
Journal:  Crit Care       Date:  2004-10-14       Impact factor: 9.097

7.  Engendering enthusiasm for sustainable disaster critical care response: why this is of consequence to critical care professionals?

Authors:  Saqib I Dara; Rendell W Ashton; J Christopher Farmer
Journal:  Crit Care       Date:  2005-01-27       Impact factor: 9.097

Review 8.  Biowarfare and bioterrorism.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

Review 9.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

Review 10.  Mechanical ventilation in an airborne epidemic.

Authors:  Ghee-Chee Phua; Joseph Govert
Journal:  Clin Chest Med       Date:  2008-06       Impact factor: 2.878

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.